Clinical Trial

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-23; most recent amendment 2024-07-30.
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06385223
Lead Sponsor Institute of Mental Health, Singapore
Collaborators: National University of Singapore
Conditions Depression
Enrollment 70 participants
Start Date 2024-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-01